Given these controversial reports and inconsistent conclusion about ALT levels in patients with NAFLD, we constructed the nomogram to predict the incidence of NAFLD among individual patients with visceral fat obesity. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.